Motley Fool
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy?
📊
AI Sentiment
Positive
6/10
- Home
- MDT
MDT
Medtronic plc.
as of 03-16-2026 3:43pm EST
$87.80
+$0.71
+0.82%
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
| Founded: | 1949 | Country: | Ireland |
| Employees: | N/A | City: | GALWAY |
| Market Cap: | 131.9B | IPO Year: | 2014 |
| Target Price: | $109.82 | AVG Volume (30 days): | 7.6M |
| Analyst Decision: | Buy | Number of Analysts: | 19 |
| Dividend Yield: | Dividend Payout Frequency: | monthly | |
| EPS: | 2.76 | EPS Growth: | 30.80 |
| 52 Week Low/High: | $79.55 - $106.33 | Next Earning Date: | 05-19-2026 |
| Revenue: | $33,537,000,000 | Revenue Growth: | 3.62% |
| Revenue Growth (this year): | 8.91% | Revenue Growth (next year): | 6.75% |
| P/E Ratio: | 31.55 | Index: | |
| Free Cash Flow: | 5.2B | FCF Growth: | -1.04% |
AI-Powered MDT Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 78.31%
78.31%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Medtronic plc. (MDT)
KIIL HARRY SKIP
Sell
EVP & President Cardiovascular
MDT Feb 19, 2026
Avg Cost/Share
$97.79
Shares
52,524
Total Value
$5,132,217.24
Owned After
83,644
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| KIIL HARRY SKIP | MDT | EVP & President Cardiovascular | Feb 19, 2026 | Sell | $97.79 | 52,524 | $5,132,217.24 | 83,644 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 17, 2026 · 96% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLFeb 17, 2026 · 96% conf.
AI Prediction SELL
1D
-1.75%
$94.73
Act: +2.16%
5D
-2.26%
$94.23
Act: +0.35%
20D
-1.38%
$95.08
Price: $96.41 Prob +5D: 2% AUC: 1.000
0001628280-26-008300
mdt-202602170001613103H91 VY19false00016131032026-02-172026-02-170001613103mdt:A1.125SeniorNotesDue2027Member2026-02-172026-02-170001613103mdt:A0.375SeniorNotesDue2028Member2026-02-172026-02-170001613103mdt:A3.000SeniorNotesDue2028Member2026-02-172026-02-170001613103mdt:A3.650SeniorNotesDue2029Member2026-02-172026-02-170001613103mdt:A2.950SeniorNotesDue2030Member2026-02-172026-02-170001613103mdt:A1.625SeniorNotesDue2031Member2026-02-172026-02-170001613103mdt:A1.000SeniorNotesDue2031Member2026-02-172026-02-170001613103mdt:A3.125SeniorNotesDue2031Member2026-02-172026-02-170001613103mdt:A0.750SeniorNotesDue2032Member2026-02-172026-02-170001613103mdt:A3.375SeniorNotesDue2034Member2026-02-172026-02-170001613103mdt:A3.875SeniorNotesDue2036Member2026-02-172026-02-170001613103mdt:A2.250SeniorNotesDue2039Member2026-02-172026-02-170001613103mdt:A1.500SeniorNotesDue2039Member2026-02-172026-02-170001613103mdt:A1.375SeniorNotesDue2040Member2026-02-172026-02-170001613103mdt:A4.150SeniorNotesDue2043Member2026-02-172026-02-170001613103mdt:A4.200SeniorNotesDue2045Member2026-02-172026-02-170001613103mdt:A1.750SeniorNotesDue2049Member2026-02-172026-02-170001613103mdt:A1.625SeniorNotesDue2050Member2026-02-172026-02-170001613103mdt:A4.150SeniorNotesDue2053Member2026-02-172026-02-17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2026
Medtronic plc (Exact name of Registrant as Specified in its Charter)
Ireland 1-36820 98-1183488 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
Building Two Parkmore Business Park West Galway, Ireland (Address of principal executive offices) (Zip Code) +353 1 438-1700 (Registrant’s telephone number, including area code)
Not Applicable Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange 1.125% Senior Notes due 2027MDT/27New York Stock Exchange 0.375% Senior Notes due 2028MDT/28New York Stock Exchange 3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange 3.650% Senior Notes due 2029MDT/29New York Stock Exchange 2.950% Senior Notes due 2030MDT/30New York Stock Exchange 1.625% Senior Notes due 2031MDT/31New York Stock Exchange 1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange 3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange 0.750% Senior Notes due 2032MDT/32New York Stock Exchange 3.375% Senior Notes due 2034MDT/34New York Stock Exchange 3.875% Senior Notes due 2036MDT/36New York Stock Exchange 2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange 1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange 1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange 4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange 4.200% Senior Notes due 2045MDT/45New York Stock Exchange 1.750% Senior Notes due 2049MDT/49New York Stock Exchange 1.625% Senior Notes due 2050MDT/50New York Stock Exchange 4.150% Senior Notes due 2053MDT/53New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition
On February 17, 2026, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its third quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01.Exhibits.
(d) List of Exhibits Exhibit Number Description
99.1 Press release of Medtronic plc, dated February 17, 2026
104Cover Page Interactive Data File (embedded with th
2025 Q3 Q3 2025 Earnings
8-K Nov 18, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 18, 2025
0001628280-25-052771
mdt-202511180001613103H91 VY19false00016131032025-11-182025-11-180001613103mdt:A1.125SeniorNotesDue2027Member2025-11-182025-11-180001613103mdt:A0.375SeniorNotesDue2028Member2025-11-182025-11-180001613103mdt:A3.000SeniorNotesDue2028Member2025-11-182025-11-180001613103mdt:A3.650SeniorNotesDue2029Member2025-11-182025-11-180001613103mdt:A2.950SeniorNotesDue2030Member2025-11-182025-11-180001613103mdt:A1.625SeniorNotesDue2031Member2025-11-182025-11-180001613103mdt:A1.000SeniorNotesDue2031Member2025-11-182025-11-180001613103mdt:A3.125SeniorNotesDue2031Member2025-11-182025-11-180001613103mdt:A0.750SeniorNotesDue2032Member2025-11-182025-11-180001613103mdt:A3.375SeniorNotesDue2034Member2025-11-182025-11-180001613103mdt:A3.875SeniorNotesDue2036Member2025-11-182025-11-180001613103mdt:A2.250SeniorNotesDue2039Member2025-11-182025-11-180001613103mdt:A1.500SeniorNotesDue2039Member2025-11-182025-11-180001613103mdt:A1.375SeniorNotesDue2040Member2025-11-182025-11-180001613103mdt:A4.150SeniorNotesDue2043Member2025-11-182025-11-180001613103mdt:A4.200SeniorNotesDue2045Member2025-11-182025-11-180001613103mdt:A1.750SeniorNotesDue2049Member2025-11-182025-11-180001613103mdt:A1.625SeniorNotesDue2050Member2025-11-182025-11-180001613103mdt:A4.150SeniorNotesDue2053Member2025-11-182025-11-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2025
Medtronic plc (Exact name of Registrant as Specified in its Charter)
Ireland 1-36820 98-1183488 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
Building Two Parkmore Business Park West Galway, Ireland (Address of principal executive offices) (Zip Code) +353 1 438-1700 (Registrant’s telephone number, including area code)
Not Applicable Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange 1.125% Senior Notes due 2027MDT/27New York Stock Exchange 0.375% Senior Notes due 2028MDT/28New York Stock Exchange 3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange 3.650% Senior Notes due 2029MDT/29New York Stock Exchange 2.950% Senior Notes due 2030MDT/30New York Stock Exchange 1.625% Senior Notes due 2031MDT/31New York Stock Exchange 1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange 3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange 0.750% Senior Notes due 2032MDT/32New York Stock Exchange 3.375% Senior Notes due 2034MDT/34New York Stock Exchange 3.875% Senior Notes due 2036MDT/36New York Stock Exchange 2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange 1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange 1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange 4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange 4.200% Senior Notes due 2045MDT/45New York Stock Exchange 1.750% Senior Notes due 2049MDT/49New York Stock Exchange 1.625% Senior Notes due 2050MDT/50New York Stock Exchange 4.150% Senior Notes due 2053MDT/53New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition
On November 18, 2025, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its second quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01.Exhibits.
(d) List of Exhibits Exhibit Number Description
99.1 Press release of Medtronic plc, dated November 18, 2025
104Cover Page Interactive Data File (embedded with t
2025 Q2 Q2 2025 Earnings
8-K Aug 19, 2025
2025
Q2
Q2 2025 Earnings
8-KAug 19, 2025
0001613103-25-000141
mdt-202508180001613103H91 VY19false00016131032025-08-182025-08-180001613103us-gaap:CommonStockMember2025-08-182025-08-180001613103mdt:A0.000SeniorNotesDue2025Member2025-08-182025-08-180001613103mdt:A2.625SeniorNotesDue2025Member2025-08-182025-08-180001613103mdt:A1.125SeniorNotesDue2027Member2025-08-182025-08-180001613103mdt:A0.375SeniorNotesDue2028Member2025-08-182025-08-180001613103mdt:A3.000SeniorNotesDue2028Member2025-08-182025-08-180001613103mdt:A3.650SeniorNotesDue2029Member2025-08-182025-08-180001613103mdt:A1.625SeniorNotesDue2031Member2025-08-182025-08-180001613103mdt:A1.000SeniorNotesDue2031Member2025-08-182025-08-180001613103mdt:A3.125SeniorNotesDue2031Member2025-08-182025-08-180001613103mdt:A0.750SeniorNotesDue2032Member2025-08-182025-08-180001613103mdt:A3.375SeniorNotesDue2034Member2025-08-182025-08-180001613103mdt:A3.875SeniorNotesDue2036Member2025-08-182025-08-180001613103mdt:A2.250SeniorNotesDue2039Member2025-08-182025-08-180001613103mdt:A1.500SeniorNotesDue2039Member2025-08-182025-08-180001613103mdt:A1.375SeniorNotesDue2040Member2025-08-182025-08-180001613103mdt:A4.150SeniorNotesDue2043Member2025-08-182025-08-180001613103mdt:A1.750SeniorNotesDue2049Member2025-08-182025-08-180001613103mdt:A1.625SeniorNotesDue2050Member2025-08-182025-08-180001613103mdt:A4.150SeniorNotesDue2053Member2025-08-182025-08-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2025
Medtronic plc (Exact name of Registrant as Specified in its Charter)
Ireland 1-36820 98-1183488 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
Building Two Parkmore Business Park West Galway, Ireland (Address of principal executive offices) (Zip Code) +353 1 438-1700 (Registrant’s telephone number, including area code)
Not Applicable Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange 0.000% Senior Notes due 2025MDT/25ANew York Stock Exchange 2.625% Senior Notes due 2025MDT/25BNew York Stock Exchange 1.125% Senior Notes due 2027MDT/27New York Stock Exchange 0.375% Senior Notes due 2028MDT/28New York Stock Exchange 3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange 3.650% Senior Notes due 2029MDT/29New York Stock Exchange 1.625% Senior Notes due 2031MDT/31New York Stock Exchange 1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange 3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange 0.750% Senior Notes due 2032MDT/32New York Stock Exchange 3.375% Senior Notes due 2034MDT/34New York Stock Exchange 3.875% Senior Notes due 2036MDT/36New York Stock Exchange 2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange 1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange 1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange 4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange 1.750% Senior Notes due 2049MDT/49New York Stock Exchange 1.625% Senior Notes due 2050MDT/50New York Stock Exchange 4.150% Senior Notes due 2053MDT/53New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition
On August 19, 2025, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its first quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangemen
Latest Medtronic plc. News
MDT Breaking Stock News: Dive into MDT Ticker-Specific Updates for Smart Investing
Insider Monkey
Citi Lifts PT on Johnson & Johnson (JNJ) to $274 From $250 – Here’s Why
📈
AI Sentiment
Highly Positive
8/10
Business Wire
ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera™ Mapping and Ablation System with Sphere-9™ Catheter to Ambulatory Surgery Centers
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Medtronic Leadership Shift Links ENT And Neuroscience For Future Growth Focus
📊
AI Sentiment
Positive
6/10
Simply Wall St.
Medtronic (MDT) Is Down 6.1% After Q3 Beat And Dividend Hike - Has The Bull Case Changed?
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Medtronic (MDT) Announces Quarterly Dividend of $0.71 per Share
📈
AI Sentiment
Highly Positive
9/10
Compare MDT vs Leading Stocks
See how MDT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MDT Medtronic plc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.